Low Dose Naltrexone (LDN)
Low‑dose naltrexone (LDN) is a low dose of naltrexone that is thought to briefly block opioid receptors to boost natural endorphins and support immune balance.
Rheumatoid arthritis medication regimens are complex, using multiple therapies to minimize flares and maximize symptom management. Autoimmune related symptoms like inflammatory joint pain may not be sufficiently managed with traditional options alone; many patients may also benefit from adjacent support with compounded options, such as low dose naltrexone (LDN).
In rheumatoid arthritis, the immune system targets and attacks the body’s joint linings, which can lead to permanent joint damage. Hormone replacement therapy may also have an important role to play in understanding autoimmunity. Although research is mixed for these conditions, an estrogen link exists. When combined with aggravating factors like genetic predisposition, infection, or stress, pivotal milestones like puberty, pregnancy, perimenopause, and menopause underline hormonal shifts that could impact a woman’s immune system forever.
Our Rheumatoid Arthritis Medication Offerings
Estriol and Estradiol
Estriol (E3) and estradiol (E2) are key estrogens that may work together to support hormonal balance, combining estradiol’s stronger activity with estriol’s gentler, shorter‑acting effects.
Estradiol (E2)
Estradiol is the strongest and most active of the three primary estrogens and may have a role in supporting menstrual, bone, cardiovascular, and overall cellular health.
Estriol (E3)
Estriol is a weak, naturally occurring estrogen that is gaining interest for its unique biological profile and potential immunomodulatory and menopausal‑related benefits.
Progesterone
Belmar Pharmacy offers bioidentical micronized progesterone compounds. This hormone is crucial during the reproductive years and can benefit perimenopausal and postmenopausal women particularly in areas of endometrial protection, sleep, and mood.
About Rheumatoid Arthritis (RA)
Causes
An immune system gone awry is generally the root cause of all autoimmune diseases. Autoimmune patients are affected by numerous triggers outside of their control. The immune system can attack its own organs and tissues without warning. In rheumatoid arthritis, the immune system targets and attacks the body’s joint linings, which can lead to permanent joint damage.
What causes rheumatoid arthritis is not well defined. Some possible risk factors and causes include:
- Stress can lead to physical manifestations in the body, such as autoimmune flares. When neuroendocrine hormones are triggered by physical or psychological stress, immune dysregulation can be the result.
- Environmental factors such as smoking can increase risk. Genetics too – if one or more family members has an autoimmune condition, genetic preposition may put an individual at increased likelihood for developing one as well. It doesn’t however dictate how autoimmunity will present and impact daily life.
- Triggers like bacterial and viral infections can also set the stage for immune system malfunction.
- Experiencing irregular menstrual cycles or entering menopause at an early age <45 is associated with RA.
Symptoms
Rheumatoid arthritis symptoms are characterized by joint pain, swelling, and stiffness. The immune system’s attack on the joint lining, or synovial membrane, causes the joint to become inflamed and swollen. Rheumatoid arthritis early symptoms typically begin in the hands and feet with morning joint stiffness for 30 minutes or more being common. Over time, the joint inflammation can lead to cartilage destruction, bone breakdown, and permanent disability.
Patients with existing autoimmune conditions like RA can experience flares: periods of increased inflammation. Women with RA who are pregnant and have high levels of estrogen and progesterone are generally protected against disease activity. Most experience partial or complete remission during pregnancy. RA flares and new disease onset are significantly more common postpartum, suggesting a protective effect of hormones.
Menopause status at diagnosis appears to affect the severity of RA disease presentation and progression. Studies have found that postmenopausal women diagnosed with RA appear to experience more joint destruction and physical disability than premenopausal patients.
Therapies
Finding care that limits risk while slowing disease progression could give autoimmune patients the daily freedoms they deserve. Medications like Rheumatoid Arthritis Disease Modifying Anti-rheumatic Drugs (DMARDs) such as methotrexate are considered foundational to therapy, but there is no cure.
Low Dose Naltrexone (LDN)
As a complement to standard rheumatoid arthritis therapies, LDN may help limit the need for additional chronic pain-related therapies due to its potential to increase the immune response and provide an analgesic effect in rheumatic conditions.
LDN is an immune modulator and an anti-inflammatory agent. Both mechanisms are critical for autoimmune disease management. By strengthening immune system performance and upregulating endorphins, LDN can improve quality of life for patients plagued with flares and fatigue.
Bioidentical Hormone replacement therapy (BHRT)
Studying the female sex hormone’s effect on the immune system reveals a connection between the highs and lows of estrogen levels and autoimmunity. Peak incidence of RA coincides with perimenopausal age, potentially associating estrogen deficiency to disease onset.
Research indicates BHRT with estradiol or progesterone as supplementary therapy in postmenopausal patients may improve bone density, while limiting joint inflammation and breakdown.
Commonly Asked Questions About Rheumatoid Arthritis
Chronic pain associated with autoimmune conditions like RA can be challenging to address for both patients and providers. Arthritis is an inflammatory pain and can often be improved with anti-inflammatory drugs. These include steroids like prednisone, NSAIDs (nonsteroidal anti-inflammatory drugs) like ibuprofen, and low dose naltrexone (LDN). Overall, RA pain can be associated with worsening disease that requires mainstay therapy, like methotrexate or another disease modifying antirheumatic drugs (DMARDs).
No, like most autoimmune conditions, there is no cure for RA. But early identification and therapy has been shown to significantly reduce disabling joint damage and progression of the disease into other organ systems. Many patients can reduce flares and even achieve disease remission with appropriate medical support.
An immune system gone awry is generally the root cause of all autoimmune diseases. The white blood cells (WBCs) that normally fight foreign invaders such as viruses, bacteria, and cancer, begin to attack the body’s own healthy cells. In rheumatoid arthritis, the immune system targets and attacks the body’s own joint linings causing joint pain, swelling, and stiffness in its early stages.
